Education
About Us
Working with TipRanks
Follow Us
Neurometrix (NURO)
NASDAQ:NURO
NURO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.66 - $4.73
Previous CloseN/A
Volume3.59K
Average Volume (3M)3.78K
Market Cap
$9.43M
Enterprise ValueN/A
Total Cash (Recent Filing)$14.83M
Total Debt (Recent Filing)$142.62K
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Jul 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.03
Shares Outstanding978,000
10 Day Avg. Volume6,065
30 Day Avg. Volume3,780
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)0.56
Price to Sales (P/S)0.00
P/FCF Ratio-1.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neurometrix News
PremiumCompany Announcements
Neurometrix Completes Merger and Delists from Nasdaq
PremiumCompany Announcements
Neurometrix Announces Board Changes for 2024
PremiumCompany Announcements
NeuroMetrix Merges with electroCore, Expands Quell Access
Options Prices
Currently, No data available
---
Ownership Overview
7.24% Insiders
1.29% Mutual Funds
1.12% Other Institutional Investors
98.41% Public Companies and
Individual Investors
NURO FAQ
What was Neurometrix’s price range in the past 12 months?
Neurometrix lowest stock price was $2.66 and its highest was $4.73 in the past 12 months.
What is Neurometrix’s market cap?
Neurometrix’s market cap is $9.43M.
When is Neurometrix’s upcoming earnings report date?
Neurometrix’s upcoming earnings report date is Jul 17, 2025 which is in 29 days.
How were Neurometrix’s earnings last quarter?
Currently, no data Available
Is Neurometrix overvalued?
According to Wall Street analysts Neurometrix’s price is currently Overvalued.
Does Neurometrix pay dividends?
Neurometrix does not currently pay dividends.
What is Neurometrix’s EPS estimate?
Neurometrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurometrix have?
Neurometrix has 978,000 shares outstanding.
What happened to Neurometrix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neurometrix?
Currently, no hedge funds are holding shares in NURO
Company Description
Neurometrix
NeuroMetrix, Inc. is a healthcare company focused on developing and marketing innovative medical devices and technology solutions for the treatment and management of chronic conditions, particularly within neurology. The company primarily operates in the sectors of medical devices and healthcare technology. Its core products include the Quell device, a wearable neurostimulation technology for chronic pain management, and DPNCheck, a diagnostic device for diabetic peripheral neuropathy.
Technical Analysis
Strata Skin Sciences
―
Sintx Technologies
―
Biomerica
―
Tenon Medical, Inc.
―
Autonomix Medical, Inc.
―